Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Utah Medical Products (UTMD) over the last 15 years, with Q3 2025 value amounting to 0.32.

  • Utah Medical Products' Asset Utilization Ratio fell 623.66% to 0.32 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.32, marking a year-over-year decrease of 623.66%. This contributed to the annual value of 0.32 for FY2024, which is 1813.71% down from last year.
  • Per Utah Medical Products' latest filing, its Asset Utilization Ratio stood at 0.32 for Q3 2025, which was down 623.66% from 0.32 recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' Asset Utilization Ratio registered a high of 0.44 during Q3 2022, and its lowest value of 0.32 during Q3 2025.
  • In the last 5 years, Utah Medical Products' Asset Utilization Ratio had a median value of 0.39 in 2023 and averaged 0.38.
  • In the last 5 years, Utah Medical Products' Asset Utilization Ratio crashed by 1548.59% in 2021 and then surged by 1463.16% in 2022.
  • Over the past 5 years, Utah Medical Products' Asset Utilization Ratio (Quarter) stood at 0.42 in 2021, then grew by 3.54% to 0.43 in 2022, then decreased by 12.73% to 0.38 in 2023, then decreased by 13.89% to 0.32 in 2024, then fell by 1.87% to 0.32 in 2025.
  • Its Asset Utilization Ratio was 0.32 in Q3 2025, compared to 0.32 in Q2 2025 and 0.32 in Q1 2025.